A. McCavigan

Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.

M. Parmar, T. Davison, P. Johnston, 2014 .

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

M. Salto‐Tellez, R. Fitzgerald, R. Turkington, 2019, Gut.

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.

I. Mills, D. Neal, H. Pandha, 2017, European urology.

High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

R. L. Hollis, A. Oza, G. Jayson, 2019, Cancer.

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy

I. Mills, D. McArt, S. McDade, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A TMA De-Arraying Method for High Throughput Biomarker Discovery in Tissue Research

Yinhai Wang, Andrena McCavigan, Jacqueline A. James, 2011, PloS one.

Exploration of the cGAS-STING pathway in prostate cancer.

R. Kennedy, D. Harkin, N. Mccabe, 2018 .